John Oyler

CIK: 0001042047

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)195 (87.1%)

Position reduction

Option Exercises (M)21 (9.4%)

Derivative conversions

Awards (A)5 (2.2%)

Compensation grants

Other (G, F, J, C, D, …)3 (1.3%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

ONC

BeOne Medicines Ltd.

DirectorOfficer

Discretionary Trading P&L

Holdings

Transaction History (224 total)

ONC
BeOne Medicines Ltd.
Aug 12, 2026
Sale(S)
Direct
14.1K shares at avg. $359.12$5.1M
ONC
BeOne Medicines Ltd.
Aug 12, 2026
Sale(S)
Direct
15.4K shares at avg. $357.63$5.5M
ONC
BeOne Medicines Ltd.
Aug 12, 2026
Sale(S)
Direct
2K shares at avg. $354.71$702K
ONC
BeOne Medicines Ltd.
Aug 12, 2026
Sale(S)
Direct
2.5K shares at avg. $356.43$896K
ONC
BeOne Medicines Ltd.
Aug 12, 2026
Sale(S)
Direct
20.9K shares at avg. $358.41$7.5M
ONC
BeOne Medicines Ltd.
Aug 11, 2026
Sale(S)
Direct
14.6K shares at avg. $361.47$5.3M
ONC
BeOne Medicines Ltd.
Aug 11, 2026
Sale(S)
Direct
8.1K shares at avg. $360.33$2.9M
ONC
BeOne Medicines Ltd.
Aug 11, 2026
Sale(S)
Direct
4 shares at avg. $367.00$1K
ONC
BeOne Medicines Ltd.
Aug 11, 2026
Sale(S)
Direct
13.7K shares at avg. $359.32$4.9M
ONC
BeOne Medicines Ltd.
Aug 11, 2026
Sale(S)
Direct
1.2K shares at avg. $366.31$440K
ONC
BeOne Medicines Ltd.
Aug 11, 2026
Sale(S)
Direct
11.6K shares at avg. $362.34$4.2M
ONC
BeOne Medicines Ltd.
Aug 11, 2026
Sale(S)
Direct
5.2K shares at avg. $364.31$1.9M
ONC
BeOne Medicines Ltd.
Aug 11, 2026
Sale(S)
Direct
3.2K shares at avg. $365.26$1.2M
ONC
BeOne Medicines Ltd.
Aug 11, 2026
Sale(S)
Direct
13.4K shares at avg. $363.45$4.9M
ONC
BeOne Medicines Ltd.
Aug 10, 2026
Sale(S)
Direct
21.3K shares at avg. $359.50$7.6M
ONC
BeOne Medicines Ltd.
Aug 10, 2026
Sale(S)
Direct
12.4K shares at avg. $356.62$4.4M
ONC
BeOne Medicines Ltd.
Aug 10, 2026
Sale(S)
Direct
3.7K shares at avg. $360.63$1.3M
ONC
BeOne Medicines Ltd.
Aug 10, 2026
Sale(S)
Direct
2.8K shares at avg. $351.80$990K
ONC
BeOne Medicines Ltd.
Aug 10, 2026
Sale(S)
Direct
67 shares at avg. $350.00$23K
ONC
BeOne Medicines Ltd.
Aug 10, 2026
Sale(S)
Direct
3.5K shares at avg. $355.66$1.2M
ONC
BeOne Medicines Ltd.
Aug 10, 2026
Sale(S)
Direct
15.9K shares at avg. $357.67$5.7M
ONC
BeOne Medicines Ltd.
Aug 10, 2026
Sale(S)
Direct
45K shares at avg. $358.70$16.2M
ONC
BeOne Medicines Ltd.
Aug 10, 2026
Sale(S)
Direct
3.7K shares at avg. $353.32$1.3M
ONC
BeOne Medicines Ltd.
Aug 10, 2026
Sale(S)
Direct
6.7K shares at avg. $354.78$2.4M
ONC
BeOne Medicines Ltd.
Jul 21, 2026
Sale(S)
Direct
15.4K shares at avg. $316.26$4.9M

		Type	Shares	Price		Ownership
Aug 12, 2026	ONC BeOne Medicines Ltd.	Sale(S)	14,102	$359.12	$5,064,252	Direct
Aug 12, 2026	ONC BeOne Medicines Ltd.	Sale(S)	15,396	$357.63	$5,506,147	Direct
Aug 12, 2026	ONC BeOne Medicines Ltd.	Sale(S)	1,980	$354.71	$702,320	Direct
Aug 12, 2026	ONC BeOne Medicines Ltd.	Sale(S)	2,515	$356.43	$896,426	Direct
Aug 12, 2026	ONC BeOne Medicines Ltd.	Sale(S)	20,899	$358.41	$7,490,448	Direct
Aug 11, 2026	ONC BeOne Medicines Ltd.	Sale(S)	14,569	$361.47	$5,266,268	Direct
Aug 11, 2026	ONC BeOne Medicines Ltd.	Sale(S)	8,081	$360.33	$2,911,849	Direct
Aug 11, 2026	ONC BeOne Medicines Ltd.	Sale(S)	4	$367.00	$1,468	Direct
Aug 11, 2026	ONC BeOne Medicines Ltd.	Sale(S)	13,695	$359.32	$4,920,844	Direct
Aug 11, 2026	ONC BeOne Medicines Ltd.	Sale(S)	1,200	$366.31	$439,574	Direct
Aug 11, 2026	ONC BeOne Medicines Ltd.	Sale(S)	11,568	$362.34	$4,191,548	Direct
Aug 11, 2026	ONC BeOne Medicines Ltd.	Sale(S)	5,211	$364.31	$1,898,442	Direct
Aug 11, 2026	ONC BeOne Medicines Ltd.	Sale(S)	3,176	$365.26	$1,160,079	Direct
Aug 11, 2026	ONC BeOne Medicines Ltd.	Sale(S)	13,403	$363.45	$4,871,344	Direct
Aug 10, 2026	ONC BeOne Medicines Ltd.	Sale(S)	21,254	$359.50	$7,640,826	Direct
Aug 10, 2026	ONC BeOne Medicines Ltd.	Sale(S)	12,418	$356.62	$4,428,482	Direct
Aug 10, 2026	ONC BeOne Medicines Ltd.	Sale(S)	3,680	$360.63	$1,327,130	Direct
Aug 10, 2026	ONC BeOne Medicines Ltd.	Sale(S)	2,813	$351.80	$989,603	Direct
Aug 10, 2026	ONC BeOne Medicines Ltd.	Sale(S)	67	$350.00	$23,450	Direct
Aug 10, 2026	ONC BeOne Medicines Ltd.	Sale(S)	3,476	$355.66	$1,236,261	Direct
Aug 10, 2026	ONC BeOne Medicines Ltd.	Sale(S)	15,869	$357.67	$5,675,864	Direct
Aug 10, 2026	ONC BeOne Medicines Ltd.	Sale(S)	45,044	$358.70	$16,157,076	Direct
Aug 10, 2026	ONC BeOne Medicines Ltd.	Sale(S)	3,673	$353.32	$1,297,741	Direct
Aug 10, 2026	ONC BeOne Medicines Ltd.	Sale(S)	6,717	$354.78	$2,383,028	Direct
Jul 21, 2026	ONC BeOne Medicines Ltd.	Sale(S)	15,379	$316.26	$4,863,766	Direct

1-25 of 224 transactions

…

About OYLER JOHN

OYLER JOHN (SEC CIK 0001042047) files insider reports with the SEC as Chief Executive Officer of BeOne Medicines Ltd. (ONC).

Signal8 holds 26 ownership filings by OYLER JOHN, all Form 4s, filed between Oct 10, 2024 and Aug 12, 2026. Those filings report 224 transactions, from Oct 8, 2024 to Aug 12, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on OYLER JOHN's filings is in BASEL.

Recent filings by OYLER JOHN

Aug 12, 2026: Open-market sales of ONC shares (5 lines, Form 4, code S).
Aug 11, 2026: Open-market sales of ONC shares (9 lines, Form 4, code S).
Aug 10, 2026: Open-market sales of ONC shares (10 lines, Form 4, code S).
Jul 21, 2026: Open-market sale of ONC shares (Form 4, code S).

Other insiders filing for BeOne Medicines Ltd. (ONC)

Wang Xiaodong, Director
Lee Chan Henry, SVP, General Counsel
Ball Titus B., Principal Accounting Officer
Wu Xiaobin, President and COO
Rosenberg Aaron, Chief Financial Officer
Wang Lai, President, Global Head of R&D

How to read Form 4 transaction codes